The shorts are doing everything to push the price down, however their efforts are fading due to SBB. The liquidity has dried up and BOT initiated buying is in place which is evident from completed orders (which range from 10 - 200 with majority volumes under 60)
The shorts should be bit concerned now if a Take Over offer hits the deck or Canada approval for DAYBUE is announced. The NNZ-2591 Ph-3 endorsement from FDA has put another spin and a formal letter is expected next week. EU approval for DAYBUE still forming a strong position. By early next year we should re-rate to its true value. I hope NEU management then accepts any Take Over offer.
DYOR before any buy and sell.
NEU Price at posting:
$11.68 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)